Wegovys value proposition centers on MACE risk reduction (MI, stroke, CV death) in obesity with known heart disease, aligning weight management with secondary prevention priorities
As researchers decipher how GLP-1s affect mental health, experts are worried that access to the drugs is outpacing the scientific investigation
Several cardiovascular outcome trials (CVOTs) have also reported that GLP-1 RAs may be associated with mitigating kidney-related outcomes, including albuminuria, decline in eGFR and the risk of end-stage kidney disease, independent of their effects on glycemic control 14,15,17,26,27
It also may alter ion channels in neurotransmitter junctions, which suggests it may be beneficial in Alzheimer disease patients
The distribution of frog parasites of the Douglas Lake region, Michigan